US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist

39.910
+0.090+0.23%

Close May 3 16:00 ET

40.690
+0.780+1.95%

Post 19:37 ET

5.07BMarket Cap19.00P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

61.83%388.57M

24.14%102.35M

90.15%132.41M

66.17%66.84M

81.94%86.96M

-19.81%240.11M

-0.08%82.45M

-42.80%69.64M

9.04%40.23M

-18.01%47.8M

Net income from continuing operations

39.31%281.59M

47.98%85.39M

32.78%81.84M

229.53%74.75M

-34.09%39.62M

-49.81%202.13M

-13.58%57.7M

-71.54%61.63M

-75.20%22.69M

115.48%60.11M

Operating gains losses

-67.08%611K

91.84%94K

--0

----

--1.86M

--49K

--0

--1.73M

--80K

Depreciation and amortization

70.94%84.86M

190.88%20.69M

-20.97%23.08M

64.42%20.63M

2,529.43%20.46M

1,556.36%49.64M

820.31%7.11M

3,788.55%29.2M

1,606.94%12.55M

5.42%778K

Deferred tax

-13.75%34.51M

-35.79%9.42M

-62.25%9.7M

186.53%11.51M

-70.03%3.87M

125.74%40.01M

213.30%14.68M

118.04%25.7M

---13.3M

--12.93M

Other non cash items

-166.78%-4.63M

777.43%5.68M

-313.02%-12.17M

-203.25%-286K

645.67%2.16M

-69.01%6.93M

125.44%647K

1,919.08%5.71M

-2.46%277K

-98.66%289K

Change In working capital

55.01%-38.67M

-413.80%-26.1M

137.06%22.09M

-566.37%-48.48M

143.62%13.81M

-2,399.38%-85.95M

-123.33%-5.08M

-246.70%-59.6M

116.89%10.39M

-1,195.36%-31.67M

-Change in receivables

96.02%-3.34M

-117.73%-16.89M

165.67%28.85M

-444.07%-51.5M

258.81%36.19M

-1,342.65%-83.94M

-136.71%-7.76M

-206.90%-43.93M

85.39%-9.47M

-344.00%-22.79M

-Change in inventory

-53.79%-26.88M

149.88%1.47M

165.94%3.63M

-61.44%-24.74M

-215.12%-7.25M

-337.16%-17.48M

-232.72%-2.95M

-302.24%-5.51M

-17,717.44%-15.32M

150.62%6.3M

-Change in prepaid assets

145.21%4.1M

-122.68%-1.2M

-67.66%-8.45M

3,323.84%4.87M

196.87%8.88M

21.56%-9.06M

205.02%5.3M

-639.00%-5.04M

95.68%-151K

-292.63%-9.17M

-Change in payables and accrued expense

-151.14%-12.55M

-3,007.67%-9.48M

61.85%-1.95M

-35.22%22.89M

-299.43%-24.01M

2,002.40%24.54M

-90.61%326K

-103.50%-5.11M

417.09%35.33M

9.30%-6.01M

Cash from discontinued investing activities

Operating cash flow

61.83%388.57M

24.14%102.35M

90.15%132.41M

66.17%66.84M

81.94%86.96M

-19.81%240.11M

-0.08%82.45M

-42.80%69.64M

9.04%40.23M

-18.01%47.8M

Investing cash flow

Cash flow from continuing investing activities

80.10%-96.91M

-374.86%-8.29M

-8,178.77%-83.45M

112.64%54.99M

-22.02%-60.16M

-19.87%-487.01M

99.42%-1.75M

94.05%-1.01M

-874.87%-434.95M

-8.96%-49.31M

Net PPE purchase and sale

-217.96%-15.29M

-10.75%-2.6M

-192.06%-2.94M

267.67%1.62M

-2,221.84%-11.38M

-230.13%-4.81M

-1,383.54%-2.34M

-103.23%-1.01M

-81.61%-968K

-81.48%-490K

Net business purchase and sale

--0

----

---999.12M

--0

----

Net investment purchase and sale

-116.62%-81.62M

39.33%-5.7M

---80.51M

-90.28%53.37M

0.06%-48.79M

221.26%490.92M

96.86%-9.39M

--0

1,345.65%549.12M

-8.53%-48.82M

Net other investing changes

----

--26.01M

--9.99M

--0

----

Cash from discontinued investing activities

Investing cash flow

80.10%-96.91M

-374.86%-8.29M

-8,178.77%-83.45M

112.64%54.99M

-22.02%-60.16M

-19.87%-487.01M

99.42%-1.75M

94.05%-1.01M

-874.87%-434.95M

-8.96%-49.31M

Financing cash flow

Cash flow from continuing financing activities

-212.59%-407.99M

-4,048.81%-249.92M

133.07%4.1M

-99.33%2.45M

-26,480.45%-164.61M

365.38%362.37M

104.06%6.33M

79.36%-12.4M

921.81%367.82M

-99.82%624K

Net issuance payments of debt

-102.16%-13.48M

--0

---13.48M

50.20%624.55M

--0

--254.55M

--370M

--0

Net common stock issuance

-101.19%-402.38M

-25,229,900.00%-252.3M

--0

---150.08M

42.87%-200M

100.00%-1K

-209.04%-200M

--0

Proceeds from stock option exercised by employees

-43.92%7.88M

-65.85%2.38M

55.58%4.1M

-35.99%2.45M

-267.95%-1.05M

12.08%14.05M

61.69%6.97M

-43.29%2.64M

-8.59%3.82M

203.65%624K

Net other financing activities

----

-17,877.36%-76.22M

---639K

---69.58M

----

Cash from discontinued financing activities

Financing cash flow

-212.59%-407.99M

-4,048.81%-249.92M

133.07%4.1M

-99.33%2.45M

-26,480.45%-164.61M

365.38%362.37M

104.06%6.33M

79.36%-12.4M

921.81%367.82M

-99.82%624K

Net cash flow

Beginning cash position

96.86%234.7M

85.72%274.23M

141.89%221.17M

-18.13%96.88M

96.86%234.7M

-19.56%119.22M

-70.00%147.66M

-79.57%91.43M

-76.33%118.34M

-19.56%119.22M

Current changes in cash

-200.74%-116.33M

-279.07%-155.86M

-5.63%53.06M

561.96%124.28M

-15,489.59%-137.81M

498.41%115.48M

123.34%87.04M

25.74%56.23M

48.74%-26.9M

-100.25%-884K

End cash Position

-49.56%118.37M

85.72%274.23M

141.89%221.17M

-18.13%96.88M

96.86%234.7M

-70.00%147.66M

-79.57%91.43M

-76.33%118.34M

Free cash flow

58.64%373.28M

24.53%99.76M

88.65%129.47M

74.40%68.47M

59.78%75.59M

-21.04%235.3M

-2.73%80.11M

-43.40%68.63M

7.98%39.26M

-18.47%47.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	61.83%388.57M	24.14%102.35M	90.15%132.41M	66.17%66.84M	81.94%86.96M	-19.81%240.11M	-0.08%82.45M	-42.80%69.64M	9.04%40.23M	-18.01%47.8M
Net income from continuing operations	39.31%281.59M	47.98%85.39M	32.78%81.84M	229.53%74.75M	-34.09%39.62M	-49.81%202.13M	-13.58%57.7M	-71.54%61.63M	-75.20%22.69M	115.48%60.11M
Operating gains losses	-67.08%611K	91.84%94K	--0	----	----	--1.86M	--49K	--0	--1.73M	--80K
Depreciation and amortization	70.94%84.86M	190.88%20.69M	-20.97%23.08M	64.42%20.63M	2,529.43%20.46M	1,556.36%49.64M	820.31%7.11M	3,788.55%29.2M	1,606.94%12.55M	5.42%778K
Deferred tax	-13.75%34.51M	-35.79%9.42M	-62.25%9.7M	186.53%11.51M	-70.03%3.87M	125.74%40.01M	213.30%14.68M	118.04%25.7M	---13.3M	--12.93M
Other non cash items	-166.78%-4.63M	777.43%5.68M	-313.02%-12.17M	-203.25%-286K	645.67%2.16M	-69.01%6.93M	125.44%647K	1,919.08%5.71M	-2.46%277K	-98.66%289K
Change In working capital	55.01%-38.67M	-413.80%-26.1M	137.06%22.09M	-566.37%-48.48M	143.62%13.81M	-2,399.38%-85.95M	-123.33%-5.08M	-246.70%-59.6M	116.89%10.39M	-1,195.36%-31.67M
-Change in receivables	96.02%-3.34M	-117.73%-16.89M	165.67%28.85M	-444.07%-51.5M	258.81%36.19M	-1,342.65%-83.94M	-136.71%-7.76M	-206.90%-43.93M	85.39%-9.47M	-344.00%-22.79M
-Change in inventory	-53.79%-26.88M	149.88%1.47M	165.94%3.63M	-61.44%-24.74M	-215.12%-7.25M	-337.16%-17.48M	-232.72%-2.95M	-302.24%-5.51M	-17,717.44%-15.32M	150.62%6.3M
-Change in prepaid assets	145.21%4.1M	-122.68%-1.2M	-67.66%-8.45M	3,323.84%4.87M	196.87%8.88M	21.56%-9.06M	205.02%5.3M	-639.00%-5.04M	95.68%-151K	-292.63%-9.17M
-Change in payables and accrued expense	-151.14%-12.55M	-3,007.67%-9.48M	61.85%-1.95M	-35.22%22.89M	-299.43%-24.01M	2,002.40%24.54M	-90.61%326K	-103.50%-5.11M	417.09%35.33M	9.30%-6.01M
Cash from discontinued investing activities
Operating cash flow	61.83%388.57M	24.14%102.35M	90.15%132.41M	66.17%66.84M	81.94%86.96M	-19.81%240.11M	-0.08%82.45M	-42.80%69.64M	9.04%40.23M	-18.01%47.8M
Investing cash flow
Cash flow from continuing investing activities	80.10%-96.91M	-374.86%-8.29M	-8,178.77%-83.45M	112.64%54.99M	-22.02%-60.16M	-19.87%-487.01M	99.42%-1.75M	94.05%-1.01M	-874.87%-434.95M	-8.96%-49.31M
Net PPE purchase and sale	-217.96%-15.29M	-10.75%-2.6M	-192.06%-2.94M	267.67%1.62M	-2,221.84%-11.38M	-230.13%-4.81M	-1,383.54%-2.34M	-103.23%-1.01M	-81.61%-968K	-81.48%-490K
Net business purchase and sale	--0	--0	--0	----	----	---999.12M	--0	--0	----	----
Net investment purchase and sale	-116.62%-81.62M	39.33%-5.7M	---80.51M	-90.28%53.37M	0.06%-48.79M	221.26%490.92M	96.86%-9.39M	--0	1,345.65%549.12M	-8.53%-48.82M
Net other investing changes	----	----	----	----	----	--26.01M	--9.99M	--0	----	----
Cash from discontinued investing activities
Investing cash flow	80.10%-96.91M	-374.86%-8.29M	-8,178.77%-83.45M	112.64%54.99M	-22.02%-60.16M	-19.87%-487.01M	99.42%-1.75M	94.05%-1.01M	-874.87%-434.95M	-8.96%-49.31M
Financing cash flow
Cash flow from continuing financing activities	-212.59%-407.99M	-4,048.81%-249.92M	133.07%4.1M	-99.33%2.45M	-26,480.45%-164.61M	365.38%362.37M	104.06%6.33M	79.36%-12.4M	921.81%367.82M	-99.82%624K
Net issuance payments of debt	-102.16%-13.48M	--0	--0	--0	---13.48M	50.20%624.55M	--0	--254.55M	--370M	--0
Net common stock issuance	-101.19%-402.38M	-25,229,900.00%-252.3M	--0	--0	---150.08M	42.87%-200M	100.00%-1K	-209.04%-200M	--0	--0
Proceeds from stock option exercised by employees	-43.92%7.88M	-65.85%2.38M	55.58%4.1M	-35.99%2.45M	-267.95%-1.05M	12.08%14.05M	61.69%6.97M	-43.29%2.64M	-8.59%3.82M	203.65%624K
Net other financing activities	----	----	----	----	----	-17,877.36%-76.22M	---639K	---69.58M	----	----
Cash from discontinued financing activities
Financing cash flow	-212.59%-407.99M	-4,048.81%-249.92M	133.07%4.1M	-99.33%2.45M	-26,480.45%-164.61M	365.38%362.37M	104.06%6.33M	79.36%-12.4M	921.81%367.82M	-99.82%624K
Net cash flow
Beginning cash position	96.86%234.7M	85.72%274.23M	141.89%221.17M	-18.13%96.88M	96.86%234.7M	-19.56%119.22M	-70.00%147.66M	-79.57%91.43M	-76.33%118.34M	-19.56%119.22M
Current changes in cash	-200.74%-116.33M	-279.07%-155.86M	-5.63%53.06M	561.96%124.28M	-15,489.59%-137.81M	498.41%115.48M	123.34%87.04M	25.74%56.23M	48.74%-26.9M	-100.25%-884K
End cash Position	-49.56%118.37M	-49.56%118.37M	85.72%274.23M	141.89%221.17M	-18.13%96.88M	96.86%234.7M	96.86%234.7M	-70.00%147.66M	-79.57%91.43M	-76.33%118.34M
Free cash flow	58.64%373.28M	24.53%99.76M	88.65%129.47M	74.40%68.47M	59.78%75.59M	-21.04%235.3M	-2.73%80.11M	-43.40%68.63M	7.98%39.26M	-18.47%47.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall